4//SEC Filing
Stengone Carmine N. 4
Accession 0001437749-25-002424
CIK 0001855175other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:35 PM ET
Size
5.3 KB
Accession
0001437749-25-002424
Insider Transaction Report
Form 4
Stengone Carmine N.
DirectorCEO and President
Transactions
- Award
Stock Option (right to buy)
2025-01-31+300,000→ 300,000 totalExercise: $9.79Exp: 2035-01-30→ Class A Common Stock (300,000 underlying)
Footnotes (1)
- [F1]Options granted under the Issuer's 2024 Equity Incentive Plan. 25% of the option shares vest on January 1, 2026, and the remainder vests in equal monthly installments over the next 36 months thereafter, subject to the Reporting Person's continuous service.
Documents
Issuer
Contineum Therapeutics, Inc.
CIK 0001855175
Entity typeother
Related Parties
1- filerCIK 0001861519
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 4:35 PM ET
- Size
- 5.3 KB